MEDULLOBLASTOMA, SHH-ACTIVATED AND TP53 WILDTYPE

Clinical trials for MEDULLOBLASTOMA, SHH-ACTIVATED AND TP53 WILDTYPE explained in plain language.

Never miss a new study

Get alerted when new MEDULLOBLASTOMA, SHH-ACTIVATED AND TP53 WILDTYPE trials appear

Sign up with your email to follow new studies for MEDULLOBLASTOMA, SHH-ACTIVATED AND TP53 WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists seek clues in brain tumors to forge future cures

Knowledge-focused Recruiting now

This study aims to create a collection of medical information and biological samples from patients with a specific type of recurrent brain tumor called SHH medulloblastoma, particularly those with a U1 gene mutation. Researchers will gather data from up to 300 patients and their …

Matched conditions: MEDULLOBLASTOMA, SHH-ACTIVATED AND TP53 WILDTYPE

Sponsor: Mohammad H. Abu Arja • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:41 UTC

MEDULLOBLASTOMA, SHH-ACTIVATED AND TP53 WILDTYPE

Get alerted when new MEDULLOBLASTOMA, SHH-ACTIVATED AND TP53 WILDTYPE trials appear

Scientists seek clues in brain tumors to forge future cures